FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3002417 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Suna Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Fragile X Messenger Ribonucleoprotein 1, RNA Splicing. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Fragile X syndrome (FXS) is a neurodevelopmental disorder that is often modeled in Fmr1 knockout mice where the RNA-binding protein FMRP is absent. Here, we show that in Fmr1 -deficient mice, RNA mis-splicing occurs in several brain regions and peripheral tissues. To assess molecular mechanisms of splicing mis-regulation, we employed N2A cells depleted of Fmr1 . In the absence of FMRP, RNA-specific exon skipping events are linked to the splicing factors hnRNPF, PTBP1, and MBNL1. FMRP regulates the translation of Mbnl1 mRNA as well as Mbnl1 RNA auto-splicing. Elevated Mbnl1 auto-splicing in FMRP-deficient cells results in the loss of a nuclear localization signal (NLS)-containing exon. This in turn alters the nucleus-to-cytoplasm ratio of MBNL1. This redistribution of MBNL1 isoforms in Fmr1 -deficient cells could result in downstream splicing changes in other RNAs. Indeed, further investigation revealed that splicing disruptions resulting from Fmr1 depletion could be rescued by overexpression of nuclear MBNL1. Altered Mbnl1 auto-splicing also occurs in human FXS postmortem brain. These data suggest that FMRP-controlled translation and RNA processing may cascade into a general dys-regulation of splicing in Fmr1 -deficient cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
- Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island, United States of America.
ORCID-Profile: Suna Jung
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institutes of Health/National Institute of General Medical Sciences grants
- National Institutes of Health/National Institute of Neurologic Disorders and Stroke
- National Institutes of Health / National Center for Advancing Translational Sciences
- FRAXA Research Foundation
Zitieren
APA
Jung, S., Shah, S., Han, G., & Richter, J. D. (2023). FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002417
Vancouver
Jung S, Shah S, Han G, Richter JD. FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm. PLOS Biology. 2023. doi:10.1371/journal.pbio.3002417
BibTeX
@article{Jung2023,
author = {Jung, Suna and Shah, Sneha and Han, Geongoo and Richter, Joel D},
title = {FMRP deficiency leads to multifactorial dysregulation of splicing and mislocalization of MBNL1 to the cytoplasm},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3002417}
}
EUVIMED